Study of MTP 131 in patients with Fuchs' Corneal Endothelial Dystrophy

Trial Profile

Study of MTP 131 in patients with Fuchs' Corneal Endothelial Dystrophy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Mar 2016

At a glance

  • Drugs Elamipretide (Primary)
  • Indications Corneal disorders
  • Focus Therapeutic Use
  • Acronyms ReVEAL
  • Sponsors Stealth BioTherapeutics
  • Most Recent Events

    • 08 Mar 2016 According to Stealth BioTherapeutics media release, top-line data from the study are expected in the third quarter of 2016.
    • 08 Mar 2016 Status changed from planning to recruiting, as per Stealth BioTherapeutics media release.
    • 27 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top